Skip to content
10-Q

Quarterly Report

NovoCure Ltd NVCR

0001645113-26-000042

← back to feed
Filed
Apr 30, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 24, 2026 115.82M sh
Shares Diluted Q1 2026 · Mar 31, 2026 114.15M sh
Shares Diluted Q1 2026 · Dec 31, 2025 111.47M sh
Shares Diluted Q1 2026 · Mar 31, 2025 110.28M sh
Capex Q1 2026 · Mar 31, 2026 $5.15M
Capex Q1 2026 · Dec 31, 2025 $26.65M
Capex Q1 2026 · Mar 31, 2025 $10.61M
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$13.52M
Operating Cash Flow Q1 2026 · Dec 31, 2025 −$49.03M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$35.67M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $87.53M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $93.55M
Cash And Equivalents Q1 2026 · Mar 31, 2025 $127.28M
Stockholders Equity Q1 2026 · Mar 31, 2026 $330.72M
Stockholders Equity Q1 2026 · Dec 31, 2025 $340.47M
Stockholders Equity Q1 2026 · Mar 31, 2025 $361.96M
Stockholders Equity Q1 2026 · Dec 31, 2024 $360.18M
Current Liabilities Q1 2026 · Mar 31, 2026 $217.58M
Current Liabilities Q1 2026 · Dec 31, 2025 $223.23M
Total Liabilities Q1 2026 · Mar 31, 2026 $457.21M
Total Liabilities Q1 2026 · Dec 31, 2025 $463.86M
Current Assets Q1 2026 · Mar 31, 2026 $631.66M
Current Assets Q1 2026 · Dec 31, 2025 $646.73M
Total Assets Q1 2026 · Mar 31, 2026 $787.93M
Total Assets Q1 2026 · Dec 31, 2025 $804.33M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.62
Eps Diluted Q1 2026 · Dec 31, 2025 −$1.22
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.31
Eps Basic Q1 2026 · Mar 31, 2026 −$0.62
Eps Basic Q1 2026 · Dec 31, 2025 −$1.22
Eps Basic Q1 2026 · Mar 31, 2025 −$0.31
Sga Expense Q1 2026 · Mar 31, 2026 $85.85M
Sga Expense Q1 2026 · Dec 31, 2025 $177.67M
Sga Expense Q1 2026 · Mar 31, 2025 $44.77M
Rd Expense Q1 2026 · Mar 31, 2026 $58.34M
Rd Expense Q1 2026 · Dec 31, 2025 $224.54M
Rd Expense Q1 2026 · Mar 31, 2025 $53.78M
Net Income Q1 2026 · Mar 31, 2026 −$71.14M
Net Income Q1 2026 · Dec 31, 2025 −$136.23M
Net Income Q1 2026 · Mar 31, 2025 −$34.32M
Operating Income Q1 2026 · Mar 31, 2026 −$67.42M
Operating Income Q1 2026 · Dec 31, 2025 −$153.8M
Operating Income Q1 2026 · Mar 31, 2025 −$37.87M
Gross Profit Q1 2026 · Mar 31, 2026 $135.13M
Gross Profit Q1 2026 · Dec 31, 2025 $488.47M
Gross Profit Q1 2026 · Mar 31, 2025 $116.47M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $38.93M
Cost Of Revenue Q1 2026 · Dec 31, 2025 $166.88M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $38.52M
Revenue Q1 2026 · Mar 31, 2026 $174.06M
Revenue Q1 2026 · Dec 31, 2025 $655.35M
Revenue Q1 2026 · Mar 31, 2025 $154.99M